Biocon Limited
BIOCON
Classement en actions
#3433
Biocon Limited functions as a biopharmaceutical firm, engaged in the production... Biocon Limited functions as a biopharmaceutical firm, engaged in the production of pharmaceutical, medicinal chemical, and plant-derived products. Its business activities are organized into distinct segments: Generics, Novel Biologics, Biosimilars, and Research Services. The company dedicates its efforts to crucial therapeutic domains, including diabetes, oncology, immunology, ophthalmology, and bone health disorders. Furthermore, Biocon provides comprehensive services encompassing the discovery, development, and manufacturing of both small and large molecules. With a wide international presence, it caters to customers in roughly 120 nations. Headquartered in Bengaluru, India, Biocon Limited commenced operations in 1978.
Prix de l'action
$3.69
Capitalisation boursière
$5.05B
Changement (1 jour)
-1.56%
Changement (1 an)
-11.19%
Pays
IN
Échange Biocon Limited (BIOCON)
Catégorie
Healthcare
Revenus pour Biocon Limited (BIOCON)
Revenus en Jun 2026 TTM : $1.91B
Selon les derniers rapports financiers de Biocon Limited, le chiffre d'affaires actuel de l'entreprise (TTM) est de $1.91B. En 2024, l'entreprise a réalisé un chiffre d'affaires de $1.77B une augmentation par rapport à le chiffre d'affaires de l'année 2023, qui était de $1.36B. Le chiffre d'affaires correspond au revenu total généré par la vente de biens ou de services. Contrairement au bénéfice, aucune dépense n'est déduite.
Historique des revenus pour Biocon Limited de 2004 à 2026
Revenus à la fin de chaque année
| Année | Revenus | Changez |
|---|---|---|
| 2026 (TTM) | $1.91B | 6.92% |
| 2025 | $1.78B | 0.84% |
| 2024 | $1.77B | 30.15% |
| 2023 | $1.36B | 26.12% |
| 2022 | $1.08B | 10.49% |
| 2021 | $975.78M | 16.67% |
| 2020 | $836.33M | 5.32% |
| 2019 | $794.12M | 25.39% |
| 2018 | $633.30M | 5.55% |
| 2017 | $600.02M | 18.75% |
| 2016 | $505.27M | 2.04% |
| 2015 | $495.17M | -3.94% |
| 2014 | $515.48M | 12.70% |
| 2013 | $457.40M | 13.20% |
| 2012 | $404.08M | -21.72% |
| 2011 | $516.22M | 13.85% |
| 2010 | $453.41M | 67.79% |
| 2009 | $270.22M | 29.75% |
| 2008 | $208.27M | 9.73% |
| 2007 | $189.80M | 22.96% |
| 2006 | $154.36M | 4.28% |
| 2005 | $148.03M | 28.03% |
| 2004 | $115.62M | 0.00% |
Revenus d’entreprises similaires ou concurrentes
| Entreprise | Revenus | Différence de revenus | Pays |
|---|---|---|---|
| $12.62B | 561.69% |
US
|
|
| $2.23B | 16.78% |
US
|
|
| $15.74B | 725.22% |
AU
|
|
| - | - |
CH
|
|
| $6.02B | 215.60% |
NL
|
